A Longitudinal Study of Severe and Enduring Eating Disorders

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors. Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires. The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Healthy Volunteers: f
View:

• found to meet the criteria for an eating disorder

• being in need of treatment

• having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves).

Locations
Other Locations
Sweden
Uppsala University Hospital
RECRUITING
Uppsala
Contact Information
Primary
Martina Isaksson, PhD
martina.isaksson@uu.se
0046-706954108
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2048-12
Participants
Target number of participants: 800
Treatments
Adolescent ED cohort
Adult ED cohort
Related Therapeutic Areas
Sponsors
Collaborators: Forte, Fonden för psykisk hälsa, The Söderström König Foundation
Leads: Uppsala University Hospital

This content was sourced from clinicaltrials.gov